T 0790/11 (Sorafenib combination therapy/BAYER) of 19.04.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T079011.20170419
- Date of decision
- 19 April 2017
- Case number
- T 0790/11
- Petition for review of
- -
- Application number
- 02786842.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ARYL UREA COMPOUNDS IN COMBINATION WITH OTHER CYTOSTATIC OR CYTOTOXIC AGENTS FOR TREATING HUMAN CANCERS
- Applicant name
- Bayer HealthCare LLC
- Opponent name
- Merck Patent GmbH
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Novelty - (yes)
Inventive step - (yes)
Inventive step - reasonable expectation of success (no) - Catchword
- -
- Cited cases
- T 0939/92
- Citing cases
- -
Order
For these reasons it is decided that:
Appellant 2's appeal is dismissed.